ALLONGE TO SECOND AMENDED & RESTATED SENIOR SECURED PROMISSORY NOTEOpgen Inc • June 11th, 2018 • Services-medical laboratories
Company FiledJune 11th, 2018 IndustryTHIS ALLONGE TO SECOND AMENDED & RESTATED SENIOR SECURED PROMISSORY NOTE (the “Allonge”) is made effective as of June 11, 2018, by and between OpGen, Inc., a Delaware corporation (the “Company”), Merck Global Health Innovation Fund, LLC (the “Holder”), and, solely for the purpose of the reaffirmation and representations made in Section 3 hereof, AdvanDx, Inc., a Delaware corporation (“AdvanDx”). Capitalized terms used but not defined herein shall have the meanings assigned thereto in the Note referred to below.